149 related articles for article (PubMed ID: 12934343)
1. [Inhalation of beta-2 agonists or corticosteroids as single drugs in comparison with combination therapy of patients with COPD].
Steurer-Stey C
Praxis (Bern 1994); 2003 Jul; 92(31-32):1324-5. PubMed ID: 12934343
[No Abstract] [Full Text] [Related]
2. [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].
Vestbo J
Ugeskr Laeger; 2004 Jan; 166(4):271-4. PubMed ID: 14964108
[No Abstract] [Full Text] [Related]
3. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604
[No Abstract] [Full Text] [Related]
4. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
5. [Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too].
MMW Fortschr Med; 2003 Nov; 145(46):47. PubMed ID: 14699834
[No Abstract] [Full Text] [Related]
6. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
Vestbo J; Pauwels R; Anderson JA; Jones P; Calverley P;
Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular events in patients with COPD: TORCH study results.
Calverley PM; Anderson JA; Celli B; Ferguson GT; Jenkins C; Jones PW; Crim C; Willits LR; Yates JC; Vestbo J;
Thorax; 2010 Aug; 65(8):719-25. PubMed ID: 20685748
[TBL] [Abstract][Full Text] [Related]
8. Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study.
Korn S; Kerwin E; Atis S; Amos C; Owen R; Lassen C;
Respir Med; 2011 May; 105(5):719-26. PubMed ID: 21367594
[TBL] [Abstract][Full Text] [Related]
9. Fluticasone/salmeterol: labeling change.
Prescrire Int; 2008 Dec; 17(98):229. PubMed ID: 19418648
[TBL] [Abstract][Full Text] [Related]
10. COPD: treatments benefit patients.
Rennard SI
Lancet; 2003 Feb; 361(9356):444-5. PubMed ID: 12583937
[No Abstract] [Full Text] [Related]
11. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
Prescrire Int; 2007 Dec; 16(92):257-8. PubMed ID: 18092426
[No Abstract] [Full Text] [Related]
12. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
[TBL] [Abstract][Full Text] [Related]
13. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy in COPD: different response of COPD stages and predictivity of functional parameters.
Terzano C; Petroianni A; Ricci A; Allegra L
Eur Rev Med Pharmacol Sci; 2005; 9(4):209-15. PubMed ID: 16128040
[TBL] [Abstract][Full Text] [Related]
15. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P
Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
[TBL] [Abstract][Full Text] [Related]
16. Combined salmeterol and fluticasone for COPD.
Vassiliou V
Lancet; 2003 May; 361(9369):1651; author reply 1652-3. PubMed ID: 12747901
[No Abstract] [Full Text] [Related]
17. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
Wouters EF; Postma DS; Fokkens B; Hop WC; Prins J; Kuipers AF; Pasma HR; Hensing CA; Creutzberg EC;
Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
[TBL] [Abstract][Full Text] [Related]
18. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.
Suissa S
Am J Respir Crit Care Med; 2008 Aug; 178(4):322-3. PubMed ID: 18676961
[No Abstract] [Full Text] [Related]
19. Laryngeal findings in users of combination corticosteroid and bronchodilator therapy.
Mirza N; Kasper Schwartz S; Antin-Ozerkis D
Laryngoscope; 2004 Sep; 114(9):1566-9. PubMed ID: 15475783
[TBL] [Abstract][Full Text] [Related]
20. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
